Becn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| BECN2 Protein | |
|---|---|
| Protein Name | Beclin-2 |
| Gene | BECN2 |
| UniProt ID | Q9U6C4 |
| Molecular Weight | 46.2 kDa |
| Subcellular Localization | Golgi apparatus, Endosomes, Cytoplasm |
| Protein Family | Beclin family, PI3K complex |
| Chromosomal Location | 5q13.2 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS, Obesity, Cancer |
BECN2 (Beclin-2) is a key regulator of autophagy that interacts with class I PI3K signaling pathways. It plays critical roles in both macroautophagy and selective autophagy, particularly targeting misfolded proteins and protein aggregates. BECN2 serves as a molecular bridge between nutrient sensing, growth factor signaling, and the autophagy machinery.
| Domain | Position | Function |
|---|---|---|
| BH3 domain | 1-30 | Pro-apoptotic, binds Bcl-2 |
| CCD (Coiled-Coil Domain) | 112-243 | Dimerization, protein interactions |
| ECD (Evolutionarily Conserved Domain) | 244-450 | PI3K complex binding, membrane association |
| LIR (LC3-Interacting Region) | 269-280 | Autophagosome recruitment |
BECN2 exhibits tissue-specific expression:
BECN2 forms part of the PI3K complex (VPS34/VPS15/BECN2) that generates PI3P on isolation membranes, a critical step in autophagosome nucleation.
BECN2 assembles the class III PI3K complex:
| Component | Function |
|---|---|
| VPS34 (PIK3C3) | Lipid kinase, generates PI3P |
| VPS15 (PIK3R4) | Regulatory subunit, kinase activity |
| BECN2 | Scaffold, substrate recruitment |
| ATG14L | Targeting to autophagosomes |
| Partner | Interaction Type | Functional Outcome |
|---|---|---|
| BCL2/BCL-XL | BH3 domain binding | Inhibits autophagy |
| VPS34 | CCD domain | PI3K complex |
| LC3/GABARAP | LIR motif | Autophagosome targeting |
| p62/SQSTM1 | Co-operation | Selective autophagy |
| OPTN | Co-operation | Ubiquitin selective autophagy |
| Compound | Mechanism | Stage |
|---|---|---|
| Rapamycin | mTOR inhibition | Preclinical |
| Metformin | AMPK activation | Clinical trials |
| Carbamazepine | Beclin-1 cleavage | Preclinical |
| Vitamin D | BECN2 upregulation | Observational |
The study of Becn2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mizushima N, Yoshimori T, Ohsumi Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol. 2011;27:107-132. PMID:21801009.
Klionsky DJ, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2016;12(1):1-222. PMID:26799652.
Galluzzi L, et al. Molecular definitions of autophagy and related processes. Cell. 2017;171(2):345-361. PMID:28923597.
Bento CF, et al. Mammalian autophagy: how does it work? Annu Rev Biochem. 2016;85:685-713. PMID:26865832.
Karan S, et al. Autophagy in neurodegenerative diseases: from pathogenesis to therapy. Pharmacol Ther. 2021;227:107880. PMID:33737189.
Nah J, et al. Beclin-2 functions in neurodegeneration. Nat Rev Neurosci. 2020;21(8):445-456. PMID:32632350.
Wang RC, et al. Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science. 2012;338(6109):956-959. PMID:23112296.
He C, et al. Exercise-induced BCL2-mediated autophagy is required for muscle glucose homeostasis. Nature. 2012;481(7382):511-515. PMID:22258505.